Literature DB >> 15358760

Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism.

Lingfang Zeng1, Hailing Liao, Yi Liu, Tzong-Shyuan Lee, Minjia Zhu, Xian Wang, Michael B Stemerman, Yi Zhu, John Y-J Shyy.   

Abstract

ATP-binding cassette transporter A1 (ABCA1) is a pivotal regulator of cholesterol efflux from cells to apolipoproteins, whereas sterol-responsive element-binding protein 2 (SREBP2) is the key protein regulating cholesterol synthesis and uptake. We investigated the regulation of ABCA1 by SREBP2 in vascular endothelial cells (ECs). Our results showed that sterol depletion activated SREBP2 and increased its target, low density lipoprotein receptor mRNA, with a concurrent decrease in the ABCA1 mRNA. Transient transfection analysis revealed that sterol depletion decreased the ABCA1 promoter activity by 50%, but low density lipoprotein receptor promoter- and the sterol-responsive element-driven luciferase activities were increased. Overexpression of the N terminus of SREBP2 (SREBP2(N)), an active form of SREBP2, also inhibited the ABCA1 promoter activity. Functionally adenovirus-mediated SREBP2(N) expression increased cholesterol accumulation and decreased apoA-I-mediated cholesterol efflux. The conserved E-box motif was responsible for the SREBP2(N)-mediated inhibition since mutation of the E-box increased the basal activity of the ABCA1 promoter and abolished the inhibitory effect of SREBP2(N). Furthermore sterol depletion and SREBP2(N) overexpression induced the binding of SREBP2(N) to both consensus and ABCA1-specific E-box. Chromatin immunoprecipitation assay demonstrated that serum starvation enhanced the association of SREBP2 and the ABCA1 promoter in ECs. To correlate this mechanism pathophysiologically, we found that oscillatory flow caused the activation of SREBP2 and therefore attenuated ABCA1 promoter activity in ECs. Thus, this SREBP-regulated mechanism may control the efflux of cholesterol, which is a newly defined function of SREBP2 in ECs in addition to its role in cholesterol uptake and biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358760     DOI: 10.1074/jbc.M407817200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Regulation of lipid homeostasis by the bifunctional SREBF2-miR33a locus.

Authors:  Guido T Bommer; Ormond A MacDougald
Journal:  Cell Metab       Date:  2011-03-02       Impact factor: 27.287

Review 2.  Cholesterol in beta-cell dysfunction: the emerging connection between HDL cholesterol and type 2 diabetes.

Authors:  Liam R Brunham; Janine K Kruit; Michael R Hayden; C Bruce Verchere
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

3.  ABCG1 deficiency in mice promotes endothelial activation and monocyte-endothelial interactions.

Authors:  Angela M Whetzel; Jeffrey M Sturek; Melissa H Nagelin; David T Bolick; Abraham K Gebre; John S Parks; Anthony C Bruce; Marcus D Skaflen; Catherine C Hedrick
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-01-28       Impact factor: 8.311

4.  miR-33 links SREBP-2 induction to repression of sterol transporters.

Authors:  Tyler J Marquart; Ryan M Allen; Daniel S Ory; Angel Baldán
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

5.  Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs.

Authors:  Xuefen Xie; Hailing Liao; Huaixin Dang; Wei Pang; Youfei Guan; Xian Wang; John Y-J Shyy; Yi Zhu; Frances M Sladek
Journal:  Mol Endocrinol       Date:  2009-01-29

6.  Deletion of Scap in alveolar type II cells influences lung lipid homeostasis and identifies a compensatory role for pulmonary lipofibroblasts.

Authors:  Valérie Besnard; Susan E Wert; Mildred T Stahlman; Anthony D Postle; Yan Xu; Machiko Ikegami; Jeffrey A Whitsett
Journal:  J Biol Chem       Date:  2008-12-11       Impact factor: 5.157

7.  ABCA1 Overexpression in Endothelial Cells In Vitro Enhances ApoAI-Mediated Cholesterol Efflux and Decreases Inflammation.

Authors:  Alexis Stamatikos; Nagadhara Dronadula; Philip Ng; Donna Palmer; Ethan Knight; Bradley K Wacker; Chongren Tang; Francis Kim; David A Dichek
Journal:  Hum Gene Ther       Date:  2018-10-02       Impact factor: 5.695

8.  25-Hydroxycholesterol-3-sulfate regulates macrophage lipid metabolism via the LXR/SREBP-1 signaling pathway.

Authors:  Yongjie Ma; Leyuan Xu; Daniel Rodriguez-Agudo; Xiaobo Li; Douglas M Heuman; Phillip B Hylemon; William M Pandak; Shunlin Ren
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

9.  Overexpression of STARD3 in human monocyte/macrophages induces an anti-atherogenic lipid phenotype.

Authors:  Faye Borthwick; Anne-Marie Allen; Janice M Taylor; Annette Graham
Journal:  Clin Sci (Lond)       Date:  2010-06-22       Impact factor: 6.124

10.  Prelesional arterial endothelial phenotypes in hypercholesterolemia: universal ABCA1 upregulation contrasts with region-specific gene expression in vivo.

Authors:  Mete Civelek; Gregory R Grant; Chrysta R Irolla; Congzhu Shi; Rebecca J Riley; Oscar A Chiesa; Christian J Stoeckert; John W Karanian; William F Pritchard; Peter F Davies
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-06       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.